<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="letter" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">MSJ</journal-id>
<journal-id journal-id-type="hwp">spmsj</journal-id>
<journal-id journal-id-type="nlm-ta">Mult Scler</journal-id>
<journal-title>Multiple Sclerosis Journal</journal-title>
<issn pub-type="ppub">1352-4585</issn>
<issn pub-type="epub">1477-0970</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage UK: London, England</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/1352458512446038</article-id>
<article-id pub-id-type="publisher-id">10.1177_1352458512446038</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Letters to the Editor</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Reply: ‘Obstructive sleep apnea is associated with fatigue in multiple sclerosis’ by Kaminska et al.</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name><surname>Kaminska</surname><given-names>M</given-names></name>
<xref ref-type="aff" rid="aff1-1352458512446038">1</xref>
<xref ref-type="aff" rid="aff2-1352458512446038">2</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Kimoff</surname><given-names>RJ</given-names></name>
<xref ref-type="aff" rid="aff1-1352458512446038">1</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Trojan</surname><given-names>DA</given-names></name>
<xref ref-type="aff" rid="aff1-1352458512446038">3</xref>
</contrib>
</contrib-group>
<aff id="aff1-1352458512446038"><label>1</label>Respiratory Division and Sleep Laboratory, McGill University Health Centre, Montreal, Quebec, Canada</aff>
<aff id="aff2-1352458512446038"><label>2</label>Respiratory Division and Respiratory Epidemiology and Clinical Research Unit, McGill University Health Centre, Montreal, Quebec, Canada</aff>
<aff id="aff3-1352458512446038"><label>3</label>Department of Neurology and Neurosurgery, Montreal Neurological Institute and Hospital, McGill University Health Centre, Montreal, Quebec, Canada</aff>
<author-notes>
<corresp id="corresp1-1352458512446038">M Kaminska, Royal Victoria Hospital, Respiratory Division, Room L4.08, 687 Pine Avenue West, Montreal, Quebec, Canada, H3A 1A1 Email: <email>marta.kaminska@mcgill.ca</email></corresp>
<corresp id="corresp2-1352458512446038">DA Trojan, Montreal Neurological Institute and Hospital, 3801 University Street, Room 138, Montreal, Quebec, Canada, H3A 2B4. Email: <email>daria.trojan@mcgill.ca</email></corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>3</month>
<year>2013</year>
</pub-date>
<volume>19</volume>
<issue>3</issue>
<fpage>374</fpage>
<lpage>375</lpage>
<permissions>
<copyright-statement>© The Author(s) 2012</copyright-statement>
<copyright-year>2012</copyright-year>
<copyright-holder content-type="sage">SAGE Publications</copyright-holder>
</permissions>
</article-meta>
</front>
<body>
<p>Sir,</p>
<p>A number of factors may account for the difference in obstructive sleep apnea (OSA) prevalence between our study and that of Veauthier et al. It is noteworthy that our study was not designed to determine prevalence of OSA in multiple sclerosis (MS). Rather, the main objective was to evaluate the association between OSA and clinical symptoms. It is possible that differences in study populations accounted for a portion of the difference in OSA frequency. Subjects were, however, recruited irrespective of their sleep-related symptoms. The proportion completing the study from the number who were approached was smaller in our study than the study of Veauthier et al., 22.5% versus 47% (details regarding the number of patients approached are provided in the Results section of our manuscript). Therefore, it is possible that there may have been greater selection bias in our study population. Also, our subjects were slightly older (mean of 47.3 years versus 43.2 years in the polysomnography (PSG) group in the Veauthier study), a factor associated with increased OSA risk.</p>
<p>Technical differences may also explain some of the discrepancy in OSA prevalence. The use of home versus laboratory PSG should not have had a major impact on OSA prevalence,<sup><xref ref-type="bibr" rid="bibr1-1352458512446038">1</xref>,<xref ref-type="bibr" rid="bibr2-1352458512446038">2</xref></sup> and both studies analyzed the second night to exclude first night effects. Both studies used the same criteria for scoring respiratory events (American Academy of Sleep Medicine (AASM) 1999), and both recorded respiratory airflow with pressure sensors. However, different criteria were used for sleep scoring (Rechtschaffen &amp; Kales (R&amp;K) versus AASM 2007). Moreover, those criteria were based on different EEG electrodes. In the study by Veauthier et al. scoring of sleep stages and cortical arousals is based on C3/C4 EEG electrodes, using R&amp;K criteria. In our study, C4/C3/F3/F4/O1/O2 EEG electrodes were used. Central and occipital leads were used to score arousal, while also considering additional information detected on F3 or F4. Indeed, frontal EEG (F leads) has been found to be considerably more sensitive for arousal detection.<sup><xref ref-type="bibr" rid="bibr3-1352458512446038">3</xref></sup> Therefore, the use of the AASM 2007 recommended EEG recording and sleep scoring may result in detection of more arousal-associated respiratory events. In our study, in fact, the majority of respiratory events detected were hypopneas with arousal.</p>
<p>It could be argued that these events without associated hypoxemia are not clinically significant. However, we have found an important relation between severe fatigue and both the apnea–hypopnea index and the respiratory-related arousal index. In that fatigue is a major symptom in MS, this outcome-based finding supports the clinical relevance of hypopneas with arousal. In addition, in a non-randomized controlled study, we have found that fatigue improved significantly with OSA treatment using continuous positive airway pressure (CPAP).<sup><xref ref-type="bibr" rid="bibr4-1352458512446038">4</xref>,<xref ref-type="bibr" rid="bibr5-1352458512446038">5</xref></sup> This preliminary intervention data further validates the scoring criteria we have used and supports the concept that sleep fragmentation associated with hypopnea is in fact an important determinant of fatigue in MS patients.</p>
<p>We thank Veauthier and colleagues for their discerning comments.</p>
</body>
<back>
<fn-group>
<fn fn-type="financial-disclosure">
<label>Funding</label>
<p>This research received support from the Multiple Sclerosis Society of Canada, Fonds de Recherche en Santé du Québec, Montreal Neurological Institute.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-1352458512446038">
<label>1.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Julien</surname><given-names>JY</given-names></name>
<name><surname>Martin</surname><given-names>JG</given-names></name>
<name><surname>Ernst</surname><given-names>P</given-names></name>
<name><surname>Olivenstein</surname><given-names>R</given-names></name>
<name><surname>Hamid</surname><given-names>Q</given-names></name>
<name><surname>Lemiere</surname><given-names>C</given-names></name>
<etal/>
</person-group>. <article-title>Prevalence of obstructive sleep apnea-hypopnea in severe versus moderate asthma</article-title>. <source>J Allergy Clin Immunol</source> <year>2009</year>; <volume>124</volume>: <fpage>371</fpage>–<lpage>376</lpage>.</citation>
</ref>
<ref id="bibr2-1352458512446038">
<label>2.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Iber</surname><given-names>C</given-names></name>
<name><surname>Redline</surname><given-names>S</given-names></name>
<name><surname>Kaplan Gilpin</surname><given-names>AM</given-names></name>
<name><surname>Quan</surname><given-names>SF</given-names></name>
<name><surname>Zhang</surname><given-names>L</given-names></name>
<name><surname>Gottlieb</surname><given-names>DJ</given-names></name>
<etal/>
</person-group>. <article-title>Polysomnography performed in the unattended home versus the attended laboratory setting - Sleep Heart Health Study methodology</article-title>. <source>Sleep</source> <year>2004</year>; <volume>27</volume>: <fpage>536</fpage>–<lpage>540</lpage>.</citation>
</ref>
<ref id="bibr3-1352458512446038">
<label>3.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>O’Malley</surname><given-names>EB</given-names></name>
<name><surname>Norman</surname><given-names>RG</given-names></name>
<name><surname>Farkas</surname><given-names>D</given-names></name>
<name><surname>Rapoport</surname><given-names>DM</given-names></name>
<name><surname>Walsleben</surname><given-names>JA</given-names></name>
</person-group>. <article-title>The addition of frontal EEG leads improves detection of cortical arousal following obstructive respiratory events</article-title>. <source>Sleep</source> <year>2003</year>; <volume>26</volume>: <fpage>435</fpage>–<lpage>439</lpage>.</citation>
</ref>
<ref id="bibr4-1352458512446038">
<label>4.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Côté</surname><given-names>I</given-names></name>
<name><surname>Trojan</surname><given-names>DA</given-names></name>
<name><surname>Kaminska</surname><given-names>M</given-names></name>
<name><surname>Weiss</surname><given-names>D</given-names></name>
<name><surname>Da Costa</surname><given-names>D</given-names></name>
<name><surname>Bar-Or</surname><given-names>A</given-names></name>
<etal/>
</person-group>. <article-title>Impact of obstructive sleep apnea-hypopnea treatment on fatigue in multiple sclerosis</article-title>. <source>Am J Respir Crit Care Med</source> <year>2010</year>; <volume>181</volume>: <fpage>A2242</fpage>.</citation>
</ref>
<ref id="bibr5-1352458512446038">
<label>5.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Cote</surname><given-names>I</given-names></name>
<name><surname>Trojan</surname><given-names>D</given-names></name>
<name><surname>Kaminska</surname><given-names>M</given-names></name>
<name><surname>Cardoso</surname><given-names>M</given-names></name>
<name><surname>Benedetti</surname><given-names>A</given-names></name>
<name><surname>Weis</surname><given-names>D</given-names></name>
<name><surname>Robinson</surname><given-names>A</given-names></name>
<name><surname>Bar-Or</surname><given-names>A</given-names></name>
<name><surname>Lapierre</surname><given-names>Y</given-names></name>
<name><surname>Kimoff</surname><given-names>R</given-names></name>
</person-group>.<article-title>Impact of Sleep Disorder Treatment on Fatigue in Multiple Sclerosis</article-title>. <year>2012</year>. <comment>Manuscript in review</comment>.</citation>
</ref>
</ref-list>
</back>
</article>